To study the efficacy of a single intravitreal injection of expansile gas as a valuable alternative to current treatment options (conservative, pharmacological, and surgical) in patients with ...

An enzyme injected into the vitreous cavity in patients with vitreomacular adhesion may release focal points of contact, thus obviating the need for surgical intervention for relief of vitreomacular ...

Vitreomacular adhesion (VMA) can lead to reduced visual acuity, metamorphopsia, photopsia, and micropsia. These symptoms are explained by vitreomacular traction (VMT) at the vitreomacular junction.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Hyaloid adhesion occurs regularly in ...

ThromboGenics announced data from two Phase 3 clinical trials evaluating ocriplasmin for the treatment of vitreomacular traction (VMT) and macular holes. The studies highlight that a single ...

The composition of vitreous is 98% water and 2% structural macromolecules. Early in embryonic development, the molecular constituents of vitreous form a clear, gel-like structure that is adherent to ...

ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that Health Canada has ...

Stalmans et al. (Aug. 16 issue) 1 report that intravitreal injection of ocriplasmin was superior to injection of placebo in altering the vitreoretinal interface of affected eyes. It was associated ...

LUXEMBOURG – 28 September, 2020 – Life Science Newswire – Inceptua Group – pharmaceutical company and service partner announces that the European Commission (EC) has approved the transfer of the ...